Literature DB >> 21738155

A viral strategy to ambush tumors.

Christopher Alvarez-Breckenridge, E Antonio Chiocca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21738155      PMCID： PMC4256679          DOI： 10.1038/nm0711-784

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Cellular carriers or free viruses?

Authors:  Leonard W Seymour; Ryan Cawood; Kerry D Fisher
Journal:  Curr Opin Mol Ther       Date:  2008-08

2.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

Authors:  Heidi S Phillips; Samir Kharbanda; Ruihuan Chen; William F Forrest; Robert H Soriano; Thomas D Wu; Anjan Misra; Janice M Nigro; Howard Colman; Liliana Soroceanu; P Mickey Williams; Zora Modrusan; Burt G Feuerstein; Ken Aldape
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

3.  Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

Authors:  Marta Santisteban; Jennifer M Reiman; Michael K Asiedu; Marshall D Behrens; Aziza Nassar; Kimberly R Kalli; Paul Haluska; James N Ingle; Lynn C Hartmann; Masoud H Manjili; Derek C Radisky; Soldano Ferrone; Keith L Knutson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 4.  The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.

Authors:  Robin J Prestwich; Fiona Errington; Rosa M Diaz; Hardev S Pandha; Kevin J Harrington; Alan A Melcher; Richard G Vile
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

5.  Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy.

Authors:  Jian Qiao; Timothy Kottke; Candice Willmon; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Jill Thompson; Pamela Ryno; Glen N Barber; John Chester; Peter Selby; Kevin Harrington; Alan Melcher; Richard G Vile
Journal:  Nat Med       Date:  2007-12-09       Impact factor: 53.440

6.  Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas.

Authors:  Timothy Kottke; Jose Pulido; Jill Thompson; Luis Sanchez-Perez; Heung Chong; Stuart K Calderwood; Peter Selby; Kevin Harrington; Scott E Strome; Alan Melcher; Richard G Vile
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 8.  The host response to cancer virotherapy.

Authors:  E Antonio Chiocca
Journal:  Curr Opin Mol Ther       Date:  2008-02

9.  A simple method to cure established tumors by inflammatory killing of normal cells.

Authors:  Gregory A Daniels; Luis Sanchez-Perez; Rosa Maria Diaz; Timothy Kottke; Jill Thompson; Maoyi Lai; Michael Gough; Mahzuz Karim; Andrew Bushell; Heung Chong; Alan Melcher; Kevin Harrington; Richard G Vile
Journal:  Nat Biotechnol       Date:  2004-08-01       Impact factor: 54.908

Review 10.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962
View more
  2 in total

1.  Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.

Authors:  Jose Pulido; Timothy Kottke; Jill Thompson; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Diana Rommelfanger; Elizabeth Ilett; Larry Pease; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Biotechnol       Date:  2012-03-18       Impact factor: 54.908

2.  Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

Authors:  Nicolas Boisgerault; Timothy Kottke; Jose Pulido; Jill Thompson; Rosa Maria Diaz; Diana Rommelfanger-Konkol; Addie Embry; Dyana Saenz; Eric Poeschla; Hardev Pandha; Kevin Harrington; Alan Melcher; Peter Selby; Richard Vile
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.